Xavier Borras
Overview
Explore the profile of Xavier Borras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferres S, Serrat M, Auer W, Royuela-Colomer E, Almirall M, Lizama-Lefno A, et al.
Brain Behav Immun
. 2025 Jan;
125:184-197.
PMID: 39742894
The multicomponent intervention FIBROWALK integrates pain science education (PSE), therapeutic exercise, cognitive behavioral therapy (CBT), and mindfulness training for treating fibromyalgia (FM). This study investigated the effects of the FIBROWALK...
2.
Gallego A, Serrat M, Royuela-Colomer E, Sanabria-Mazo J, Borras X, Esteve M, et al.
Digit Health
. 2024 Mar;
10:20552076241239177.
PMID: 38550263
Objective: Fibromyalgia (FM) is a prevalent pain syndrome with significant healthcare and societal costs. The aim of the SMART-FM-SP study is to determine the effectiveness, cost-utility, and physiological effects in...
3.
Sanabria-Mazo J, DAmico F, Cardenosa E, Ferrer M, Edo S, Borras X, et al.
J Pain
. 2024 Jan;
25(7):104472.
PMID: 38242333
Chronic pain and depression are frequently comorbid conditions associated with significant health care and social costs. This study examined the cost-utility and cost-effectiveness of videoconference-based group forms of Acceptance and...
4.
Sanabria-Mazo J, Colomer-Carbonell A, Fernandez-Vazquez O, Noboa-Rocamora G, Cardona-Ros G, McCracken L, et al.
Front Psychol
. 2024 Jan;
14:1200685.
PMID: 38187407
Objective: Chronic pain frequently co-occurs with clinically relevant psychological distress. A systematic review was conducted to identify the efficacy of cognitive behavioral therapy-based interventions for patients with these comorbid conditions....
5.
Serrat M, Navarrete J, Ferres S, Auer W, Sanmartin-Sentanes R, Nieto R, et al.
Health Psychol
. 2023 Dec;
43(4):310-322.
PMID: 38127508
Objective: This study aimed to evaluate the effectiveness of an online multicomponent intervention called FATIGUEWALK (FaW) compared to treatment as usual (TAU) in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)....
6.
Sanabria-Mazo J, Colomer-Carbonell A, Borras X, Castano-Asins J, McCracken L, Montero-Marin J, et al.
J Pain
. 2023 Apr;
24(8):1522-1540.
PMID: 37105508
This study examined the efficacy of adding a remote, synchronous, group, videoconference-based form of acceptance and commitment therapy (ACT) or behavioral activation therapy for depression (BATD) to treatment-as-usual (TAU) in...
7.
Serrat M, Ferres S, Auer W, Almirall M, Lluch E, DAmico F, et al.
Front Physiol
. 2022 Dec;
13:1046613.
PMID: 36452042
The On&Out study is aimed at assessing the effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent intervention conducted in two different settings: online (FIBRO-On) or outdoors (FIBRO-Out). Both interventions...
8.
Sanabria-Mazo J, Colomer-Carbonell A, Carmona-Cervello M, Feliu-Soler A, Borras X, Grasa M, et al.
Front Immunol
. 2022 Sep;
13:945513.
PMID: 36119028
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020176153, identifier CRD42020176153.
9.
Colomer-Carbonell A, Sanabria-Mazo J, Hernandez-Negrin H, Borras X, Suso-Ribera C, Garcia-Palacios A, et al.
BMJ Open
. 2022 Jan;
12(1):e055351.
PMID: 34992118
Introduction: There is evidence that low-dose naltrexone (LDN; <5.0 mg/day) reduces pain and improves the quality of life of people with fibromyalgia syndrome (FMS). However, no randomised controlled trials with...
10.
Bermejo J, Gonzalez-Mansilla A, Mombiela T, Fernandez A, Martinez-Legazpi P, Yotti R, et al.
J Am Heart Assoc
. 2021 Jan;
10(2):e019949.
PMID: 33399006
Background The determinants and consequences of pulmonary hypertension after successfully corrected valvular heart disease remain poorly understood. We aim to clarify the hemodynamic bases and risk factors for mortality in...